Xtant Medical Withdraws 2026 Guidance After $3.6M Q3 Loss
Q3 revenue was $24.3 million, down from $33.3 million a year earlier but up 5% sequentially. Xtant reported a $3.6 million net loss, versus $1.3 million in net income a year earlier, and withdrew its prior 2026 guidance without providing a replacement during a board-led strategic review.
Story updates
12:09:05 PM UTC
SquawkNews
Xtant Medical Q3 revenue misses estimates; withdraws guidance
Q3 revenue was $24.3M, down from $33.3M a year earlier but up 5% sequentially; net loss was $3.6M versus $1.3M net income. Xtant no longer expects to meet prior 2026 guidance and is not providing revised guidance during its board-led strategic review.Material DetailsContext by AI AnalystThis is a w…